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Abstract
Cherubism (CBM) is characterized by multiple fibro-osseous lesions in jawbones and
caused by mutations in the SH3-domain binding protein 2 (SH3BP2). CBM patients also suffer
from dental abnormalities. Biochemical analyses showed that mutations in CBM lead to SH3BP2
gain-of-function because mutant SH3BP2 is protected from tankyrase-mediated proteasomal
degradation. A knock-in (KI) mouse model expressing a CBM substitution mutation (P416R) in
Sh3bp2 has been generated. Homozygous mice (Sh3bp2KI/KI) show increased systemic
inflammation and osteopenia phenotype with high serum TNF-α level, increased numbers of
macrophages and enhanced osteoclastogenesis. Heterozygous mice (Sh3bp2+/KI) exhibit
intermediate phenotype with increased bone resorption without significant elevation of TNF-α.
Here, we utilized CBM mice to study whether CBM-causing SH3BP2 mutant protein potentiates
the development of apical periodontitis. Sh3bp2+/+, Sh3bp2+/KI and Sh3bp2KI/KI male and female
mice (8 week-old) were analyzed 3, 7, 14 and 21 days after pulp exposure of the right mandibular
first molars. Left molars from the same mice without pulp exposure were used as controls. While
Sh3bp2+/+ and Sh3bp2+/KI mice recovered after initial significant weight loss for 7 days, Sh3bp2KI/KI
mice continued to lose weight through 21 days after pulp exposure. Sh3bp2KI/KI mice without
receiving dental procedures did not have significant weight loss suggesting the weight loss is
caused by the development of apical periodontitis. Radiographs by Faxitron and micro-CT showed
1) periapical bone destruction can be observed as early as day 3 in Sh3bp2KI/KI mice; 2)
significantly increased bone destruction in Sh3bp2KI/KI mice; 3) Sh3bp2+/KI mice exhibited
intermediate sizes of apical lesions. H&E staining of paraffin sections showed the most severe
periapical inflammatory bone loss in Sh3bp2KI/KI mice. Sh3bp2KI/KI mice showed significantly
higher percentage of cathepsin K-positive (+) area normalized to the bone perimeter on days 7 and

viii
14 compared to other groups. Our study suggests that Sh3bp2 gain-of-function in CBM potentiates
the development of apical periodontitis. Increased bony destruction associated with apical
periodontitis may occur in CBM patients thus close monitoring the oral health of CBM patients is
recommended as part of standard care.
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Chapter I: Introduction
Cherubism
Introduction of cherubism (CBM)
In 1933, William A. Jones defined “cherubism” as “familial multilocular cystic disease of
the jaws” due to the similarity of the classical characteristics of full round cheeks and upward cast
of the eyes to the angelic look of the cherubs immortalized by Renaissance art (Figure 1) (1, 2).
Phenotypically, CBM is characterized by bilateral expansion of the jaws with fibrous tissue
deposition (1, 3-7). The pathological facial changes appear 2–5 years after birth with initial rapid
enlargement of the jaws and regress after puberty. It affects males and females and has been
reported in patients of all racial and ethnic backgrounds (8). CBM is a rare bone disorder that is
inherited as autosomal dominant form and mutations responsible for CBM have been identified in
the SH3BP2 gene. The SH3BP2 adapter protein is required for optimal B-cell activation, thymusindependent type 2 humoral response and chemoattractant-mediated neutrophil activation (8-10).

A

B

C

Figure 1. A: Individual with CBM at age 12. The facial swelling in this severe case affects the upper and lower
jaws. B: Computed tomography three-dimensional image shows excessive bone degradation and replacement by
soft tissue masses. (3) C: Cone beam computed tomography examination scan from a CBM patient at age of 15
with osteosclerosis (2)
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Clinical diagnosis of CBM is based on the facial features, dental abnormalities and genetic
test to identify mutations in SH3BP2 gene (11). However, some CBM patients may not have
mutations in SH3BP2. Mild forms of CBM may not require treatment because CBM often
regresses spontaneously after puberty with yet unknown mechanisms. Therefore, treatment of
CBM depends on the natural course of the disease and the clinical behavior of each case (8).
Longitudinal observation in these cases are recommended until functional or emotional
disturbances demand surgical intervention. Treatment of CBM consists of conservative oral care,
local curettage of the lesions, jaw contouring, intralesional steroid injections, radiation, interferon,
and systemic calcitonin administration (1, 12). Abnormal inflammatory responses are the main
component of the pathophysiology of CBM. It has been reported that that high levels of tumor
necrosis factor (TNF-α) in the circulating blood system contribute to the progression of CBM (4).
A possible therapy to reduce TNF-α levels could be TNF-α blocker (5). Disappointedly, the antiTNF treatment only showed no to mild amelioration of CBM. Yoshitaka et al. demonstrated that
bone marrow transplant improves the inflammation and bone loss (13). More recently, SYK
inhibitor, Entospletinib, has been shown to ameliorate inflammation and bone destruction in the
Sh3bp2KI/KI male (14). SYK inhibitor has not been tested in CBM patients. Future potential
therapeutics could be related to molecular mechanisms for the action of mutant SH3BP2 such as
nuclear factor of activated T cells c1 (NFATc1) which regulates osteoclast gene expression (8).
Dental abnormalities of CBM
CBM affects tooth development and eruption of the primary and permanent dentition (15).
Dental findings of CBM include: missing teeth, malocclusion, root resorption, and premature
exfoliation of deciduous teeth. Bilateral, multilocular, expansile radiolucencies with cortical
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thinning and destruction in the ramus, angulus and corpus of both sides of the mandible are the
radiographic features of CBM. The problem of early loss of deciduous teeth, delayed development,
or eruption of the permanent teeth is difficult to treat and no satisfactory solution is available.
Histological findings resemble giant cell granulomas, which contain fibrous tissue and osteoclastlike giant cells (Figure 2) (5). Numerous small vessels with large endothelial cells and perivascular
capillary cuffing are also present. Tooth extraction may be needed if teeth are “free-floating” in
CBM lesions, or if they become ectopically impacted. Children may require prostheses that are
adjusted as the child grows. Orthodontic treatment is appropriate after growth is completed and
when CBM is regressing (5, 8). All CBM patients included in a cohort study have either partial or
complete dentures (16). Therefore, dental abnormalities can bring enormous emotional and social
disturbances to CBM patients.

A

C

Figure 2(A): Intraoral view shows missing teeth, malocclusion and swelling of the alveolar ridges. (1, 2) (B): Panoramic
radiograph shows bilateral well-defined multilocular radiolucent lesions in jawbones. (5) (C): Multinucleated giant cells are
scattered in vascular fibrous stroma with osteoid and newly formed bone matrix.(1)

Mouse model for CBM
Genetic mutation responsible for CBM was first mapped to chromosome 4p16.3 and later
identified in SH3BP2 gene (3). It has been shown that CBM mutations in SH3BP2 lead to loss of
Tankyrase-mediated protein degradation leading to excessive expression of SH3BP2 (17). Two
CBM knock-in mouse models have been generated by introducing CBM mutations (P416R or
G418R) in Sh3bp2 (4, 18). Both mouse models showed autoinflammatory lesions and osteopenia
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phenotype. Several mechanisms may account for these phenotypes in CBM mice: 1) Inflammatory
reactions caused by increased macrophage numbers with high serum TNF-α level and 2) bone
resorption caused by hyperactive osteoclasts via hyperactive SYK, SRC, VAV signaling and
increased NFATc1. SH3BP2 protein plays important roles in many types of immune cells. In
mouse models with ablated SH3BP2 genes there is a perturbation in the peritoneal B1 and splenic
marginal-zone B-cell compartments suggesting SH3BP2 is required for optimal B-cell activation
(10). CBM mutant SH3BP2 protein enhanced B-cell receptor signaling (19). In Sh3bp2KI/KI mice,
it was found that inflammatory lesions develop independently of B- or T-cell involvement (4).
Yoshitaka et al. demonstrated that the inflammation in CBM mice was rescued in the absence of
Toll-like receptors (TLRs) 2 and 4 (20). Mutant macrophages are hyper-responsive to pathogenassociated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) that
activate TLRs resulting in TNF-α over-production. The presence of a large amount of TLR ligands,
oral bacteria and DAMPs during jawbone remodeling, may cause the jaw-specific development of
human CBM lesions. Reduced levels of DAMPs after stabilization of jaw remodeling may
contribute to the age-dependent regression (20).
To date, it has never been studied whether CBM patients respond to bacteria challenges
leading to apical periodontitis (AP) differently when compared to healthy subjects. Our study uses
a knock-in mouse model expressing the most common mutation identified in CBM, P416R
(proline-to-arginine substitution) (4). Both Sh3bp2+/KI and Sh3bp2KI/KI mice have osteopenia
phenotype caused by increased bone resorption (Figure 3). Furthermore, Sh3bp2KI/KI mice also
have increased serum TNF-α levels which is a pro-inflammatory cytokine [1]. We aim to examine
how AP develop differently in Sh3bp2+/+, Sh3bp2+/KI and Sh3bp2KI/KI mice.
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Figure 3. MicroCT images of (A) cross sections through 1st molar furcation showing incisors; (B) reconstructed threedimensional mandibles of Sh3bp2+/+, Sh3bp2+/KI and Sh3bp2KI/KI male littermates. Arrows indicate abnormal pits on
mandibular surface. (C) Three-dimensional microCT images of metaphyseal trabecular bones in Sh3bp2+/+, Sh3bp2+/KI
and Sh3bp2KI/KI male littermates. (4)

Apical periodontitis
Etiology
The etiology, pathogenesis, and histopathology of AP are very similar to that of marginal
periodontitis. Both diseases are caused by bacterial infection and involve pathologic changes of
alveolar bone, periodontal ligament, and cementum. Marginal periodontitis affects coronal
periodontal tissues, whereas AP affects apical periodontal tissues. Bone loss is one of characteristic
features in both diseases: crestal bone is lost in marginal periodontitis, and apical bone undergoes
resorption in AP. AP can be caused by both exogenous and endogenous factors. Exogenous factors
include microbes and their toxins and noxious metabolic byproducts, chemical agents, mechanical
irritation, foreign bodies, and trauma. Endogenous factors include the host’s metabolic products,
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such as urate and cholesterol crystals, as well as cytokines or other inflammatory mediators. Both
factors induce immune-inflammatory responses (21).
However, infection of the pulp tissue caused by caries or other pathways is the primary
cause of AP (22, 23). The outcome of pulpal insult is a dynamic process and it depends on the
invading microorganisms and host responses (24, 25). The role of microorganisms is discussed in
the next section.
Based on the patient’s symptoms and the radiographic presentation, AP can be
symptomatic (SAP) or asymptomatic (AAP) (26-28). Clinical features of SAP include a painful
response to biting and/or percussion or palpation. SAP can also result in severe spontaneous,
throbbing, and occasionally radiating pain to neck or head. It might or might not be associated
with a periapical radiolucency area, and radiographs may show a widened periodontal ligament.
Histologically, polymorphonuclear leukocytes and macrophages, and possibly, liquefaction
necrosis in small areas of the pulp are observed (28). AAP does not produce clinical symptoms
and has an unremarkable response to percussion or palpation. Radiographic images may show a
break in the lamina dura to a large periapical radiolucency, and histologic images would be
consistent with a periapical granuloma or an apical cyst (27).
Microorganisms
Bacteria
Bacteria are considered the primary cause of AP which most part arise from the normal
oral microbiota under predisposing conditions (29-31). Although more than 500 different bacteria
species have been identified in association with endodontic infections using different culture and
molecular methods, 20-40 of them are more frequently involved in AP (32-34). From the literature,
it is evident that there is no single named species involved in disease etiology when bacterial
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community profiles are considered, meaning that associations of any specific species with AP is
rarely. However, any species found in the canal may play a role in the pathology and ecology of
the microbial community (32). It has been shown that the severity of pulpal/periapical
inflammation has been directly correlated with the total microbial content within root canals, and
with the length of time the periapical tissues were exposed to the infecting microorganisms (35).
In the advanced stage of the infectious process, bacteria are characterized by a mixed community
arranged in biofilms (29, 30). Therefore, AP can be considered a human infection disease caused
by bacteria biofilms in the root canal, which release products that accumulate in the periradicular
tissues giving rise to an inflammatory response that may lead to destruction of the periodontal
ligament and bone (30, 32).
Several studies have tried to correlate some bacterial species with SAP or AAP, but the
same species can also be found in both cases (31, 36-39). Anaerobic bacteria are dominated in
primary infection with an overall bacteria density of 103 to 108, and the time of infection can
influence this dominance increasing the level of bacteria at late stages of infection (40-45).
Bacterial species frequently detected in SAP and AAP belong to diverse genera of gram-negative
(i.e.

Fusobacterium,

Porphyromonas,

Prevotella,

Dialister,

Tannerella,

Treponema,

Campylobacter, and Veillonella) and gram-positive (i.e. Actinomyces, Peptostreptococcus,
Parvimonas, Filifactor, Pseudoramibacter, Olsenella, Streptococcus, Propionibacterium, and
Eubacterium) (31, 34, 38, 46-50). In terms of amounts of bacteria, SAP cases showed higher levels
than AAP cases (32, 34, 38, 47). The purpose of endodontic treatment of AP is to eliminate the
infection in root canal system and relief patients’ symptoms. After root canal treatment, the level
of bacteria decreases to 102-105 per sample, and gram-negative bacteria are less common to be
found than gram-positive bacteria (41, 51-58). In secondary infection, adequate endodontic root
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canal treatment may contain 15 species, whereas, inadequate treatment may reach up to 30 species
(59-62). In teeth with persistent infection, the bacterial density increases to 103-107 cells (42, 54,
63).
The role of specific mixture of bacteria in association with AAP and SAP is still unclear.
The inconsistency in terms of bacteria species prevalence in AAP and SAP cases can be explained
by the following factors: sampling technique, sensitivity of the identification method, geographic
location, patient’s age, accuracy or divergence in clinical diagnosis, disease classification,
differences in virulence among strains of the same species, bacterial interactions among species in
mixed communities, bacterial population density, incomplete root canal treatment, host resistance,
environmental factors, and genetic patterns (32, 49, 64, 65). Another important consideration is
uncultivated bacteria which may play a role in AAP and SAP. With molecular methods exhibiting
a higher resolution to disclose the diversity and complexity of most endogenous infections, more
complex bacterial interactions have been found in AP (66). Table 1 shows the summary of the
occurrence of bacteria in AP based on the studies.
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Table 1- Occurrence of bacteria in symptomatic (SAP) and asymptomatic (AAP) apical periodontitis.

SAP

AAP

Results

D. invisus, P.
endodontalis, S. moorei,
P. acnes, and
Streptococcus sp.

D. invisus, F. nucleatum, and
P. endodontalis.

F. nucleatum sp,
Veillonella parvula,
Treponema socranskii,
Tannerella forsythia,
Enterococcus faecalis,
and Campylobacter
gracilis…
Fusobacterium sp.,
Peptostreptococcus
micros, Porphyromonas
gingivalis, Treponema
socranskii, B. forsythus,
Prevotella nigrescens.
Filifactor alocis,
Treponema denticola,
Tannerella forsythia.

F. nucleatum sp., E. faecalis,
Eubacterium saburreum, and
Neisseria mucosa,
Peptostreptococcus
micros...

Species formed different partnerships and
associations in samples from teeth with or without
pain. The most prevalent bacteria in SAP cases were
D. invisus, P. endodontalis, S. moorei,
Propionibacterium acnes, and Streptococcus species.
Significant difference was observed in the total levels
of bacteria in SAP and AAP cases. Association was
found between higher total bacterial counts and levels
of T. forsythia and the presence of pain.
Propionibacterium acnes were reduced in
symptomatic cases.

F. necrophorum, P.
prevotii, P. micros, S.
sanguis, F nucleatum, P.
intermedia. G.
morbillorum, Veillonella
spp…
P. intermedia, P.
gingivalis, P.
endodontalis, P. micros,
Enterococcus sp.,
Streptococcus sp., F.
nucleatum…
Campylobacter genus,
Enterobacteriaceae genus,
Fusobacterium genus,
Leptotrichia genus,
Filifactor alocis,

F. necrophorum, P. prevotii,
P. micros, S. sanguis, F
nucleatum, P. intermedia. G.
morbillorum, Veillonella
spp…

Fusobacterium sp.,
Peptostreptococcus sp,
Prevotella sp.,
Mogibacterium sp,
Lachnospiraceae sp.,
Filifactor alocis, …
Enterococcus faecalis

Fusobacterium sp.,
Peptostreptococcus sp,
Prevotella sp., Mogibacterium
sp, Lachnospiraceae sp.,
Filifactor alocis,...

Fusobacterium sp.,
Peptostreptococcus micros,
Porphyromonas gingivalis,
Treponema socranskii, B.
forsythus. Prevotella
nigrescens.
Filifactor alocis, Treponema
denticola, Tannerella
forsythia.

P. intermedia, P. gingivalis,
P. micros, Enterococcus sp.,
Streptococcus sp., F.
nucleatum, T. forsythensis, T.
denticola, …
Campylobacter genus,
Enterobacteriaceae genus,
Acinetobacter genus,
Photorhabdus luminescens,

Enterococcus faecalis

Higher level of bacteria was observed in SAP than
AAP cases. Significant relationships were shown in
the combination of B. forsythus/P. gingivalis and
Treponema sp./ P. gingivalis. There was no
significant association between any bacteria and any
symptoms.
F. alocis, T. forsythia, and T. denticola were
associated with endodontic signs and symptoms. F.
alocis and T. forsythia were detected more frequently
in teeth with necrotic pulp than in teeth with failing
endodontic treatment.
Higher level of bacteria was observed in SAP than
AAP cases. Associations were found between
spontaneous pain and Prevotella spp. and Bacteroides
spp. Tenderness to percussion was related to
Bifidobacterium spp., Actinomyces spp. and S.
constellatus.
T. denticola, D. invisus, Olsenella uli and Synergistes
sp. were detected in the asymptomatic but not the
symptomatic patient. P. endodontalis was found in
SAP but not in AAP. All other species except
enterococci were detected.
Similarities to species of the Campylobacter genus,
and Enterobacteriaceae genus found in AAP and SAP
cases; Fusobacterium genus in SAP cases;
Acinetobacter genus in AAP cases. Significant
differences in the predominant bacterial composition
between AAP and SAP cases were observed.
Bacteroides sp. and Dialister sp. were detected only
in AAP cases. F. nucleatum, P. intermedia, D.
pneumosintes, Prevotella sp and some phylotypes
were exclusively detected in SAP cases. The
structure of the microbiota differs significantly
between AAP and SAP infections.
E. faecalis was significantly more associated with
AAP than with SAP cases, and was much more likely

Ref

(31)

(38)

(34)

(46)

(47)

(48)

(49)

(50)

(67)
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T. denticola, T. forsythia
and P. gingivalis.
Porphyromonas gingivalis

Enterococcus faecalis,
Candida albicans and
Porphyromonas
gingivalis…
Eubacterium sp,
Bacteroides sp,
Peptostreptococcus sp.,
Streptococcus sp.
Bacteroides
melaninogenicus
Firmicutes,
Proteobacteria,
Actinobacteria,
Bacteroidetes and
Fusobacteria…
P. micros, F.
necrophorum, F.
nucleatum, P.
intermedia/nigrescens, P.
gingivalis, and P.
endodontalis.
Red complex: B.
forsythus, P. gingivalis,
and T. denticola
E. faecalis, P. gingivalis,
P. intermedia, T.
forsythensis, T. denticola
P. gingivalis, T. denticola,
and T. forsythia
Prevotella spp,
Fusobaterium spp,
Peptostreptococcus spp,
Enterococcus spp…
Bacteria and archaea

F. nucleatum, B.
intermedius, P.
anaerobius, P. micros,
Lactobacillus sp., E.

T. denticola, T. forsythia and
P. gingivalis.
Porphyromonas gingivalis

Enterococcus faecalis,
Candida albicans and
Porphyromonas gingivalis…
Streptococci sp,
Peptostreptococcus sp,
Actinomyces sp.
Bacteroides melaninogenicus
Firmicutes, Proteobacteria,
Actinobacteria, Bacteroidetes
and Fusobacteria…

to be found in cases of failed endodontic therapy than
in primary infections.
Bacteria were mostly associated with SAP, and only
sporadically detected in patients with AAP.
P. gingivalis was found in 44.5% of specimens with
symptoms. Types II (69.4%) were the most frequent
in the SAP cases followed by type IV (32.7%). The
occurrence of type I (64.3%) was significantly higher
in AAP.
Association were found between SAP and
combination Prevotella spp., Treponema spp.,
Peptostreptococcaceae sp. HOT-113, Olsenella uli,
Slackia exigua, Selemonas infelix, P. gingivalis.
Bacteroides and P. magnus were more frequently
detected in SAP cases, while Streptococci and
Enteric bacteria in AAP cases.
B. melaninogenicus was found to be significantly
related to pain, sinus tract formation.
SAP patients had more Firmicutes and Fusobacteria
than AAP patients, while AAP patients showed more
Proteobacteria and Actinobacteria. The comparison
of SAP and AAP patients showed a clear association
of the composition of the bacterial community with
the presence and absence of symptoms in conjunction
with the patients’ age
Relationships were found between anaerobes,
especially gram-negatives, and the presence or
history of pain, tenderness to percussion and
swelling. Associations were found between SAP and
P. micros, P. intermedia/nigrescens and Eubacterium
spp.
No particular signs or symptoms were associated
with the presence of these red complex bacterial
species.
T. denticola was detected in teeth with SAP in the
presence of apical bone resorption. E. faecalis was
associated with treatment failures.
P gingivalis, T denticola, and T forsythia were
detected in 46%, 38%, and 22% of SAP cases, with
spontaneous pain, tenderness to percussion, swelling,
and pain on palpation.
Significant associations between pain or history of
pain and polymicrobial infections or anaerobes in
root-filled teeth SAP.
Bacteria were detected in 93% of root canal samples,
and archaea in 38%. The incidence of SAP cases
positive for both bacteria and archaea (73%) were
significantly higher than those positive for bacteria
alone (45%).
77% of root canals containing black-pigmented
Bacteroides species were associated with acute apical
abscesses and purulent drainage through the root
canal. 25% of teeth with black-pigmented
Bacteroides were asymptomatic.

(68)

(69)

(70)

(71)
(72)

(64)

(73)

(74)
(75)

(76)

(62)

(77)

(78)
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lentum, E. alactolyticum,
Bacteroides sp…
B. forsythus, P. gingivalis,
S. constellatus, P.
intermedia, P. nigrescens
…
Actinomyces,
Lactobacillus, blackpigmented Bacteroides,
Peptostreptococcus,

The results suggest that acute periradicular abscesses
is polymicrobial and are the main cause of pain and
swelling.
Of the 50 bacterial isolates, 34 (68%) were strict
anaerobes. This study demonstrates the presence of
predominantly anaerobic bacteria in the apical 5 mm
of infected root canals in SAP teeth.

(79)

(45)
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Fungi
Fungi are eukaryotic microorganisms that can be found in endodontic infections and
participate in the etiology of periradicular diseases (80, 81). They possess virulence attributes such
as adaptability and adhesion to several environmental conditions, the production of hydrolytic
enzymes, morphologic transition, biofilm formation, evasion and immunomodulation of the host
defense (80, 82). Fungi have occasionally been found in AP with primary infections, but they
appear to occur more often in the treated root canals in which treatment has failed (54, 60-62, 83,
84). The most important oral fungi are the family of Candida. Candida albicans is the most
commonly species isolated from infected root canals, and it is known as dentinophilic
microorganism because of its invasive affinity to dentin (80, 81). Egan et al. reported that C.
albicans was more frequent in root canal-treated teeth (6.7%) than non-treated teeth (3.3%) with
AP (85). In another study, C. albicans was found in 9% of symptomatic root canal treated teeth
with persistent periradicular lesions, confirming that it takes part in the microbiota associated with
failed endodontic therapy (60). C. albicans was found in association with Streptococcus spp in
unsealed teeth (62). Dumani et al. showed that C. albicans and E. faecalis were associated with
AP in primary and secondary infections (86). C. albicans was found in 36% of patients with
periapical lesions and 13% in patients without periapical lesions, suggesting that the elimination
of this microorganism from the root canal system, using appropriate intracanal solutions and
medications is of utmost importance (87). In another study, it was investigated the prevalence of
E. faecalis and C. albicans in the root filled teeth associated with SAP. The result showed that E.
faecalis was found to be prevalent species, detected in 65% of the cases and C. albicans was
detected in 35% of cases. The authors suggest that geographical influence and dietary factors might
have some role to play in the prevalence of the species like C. albicans and presence of E. faecalis
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(88). Machado et al. reported a higher Candida adherence of samples isolated from patients with
AP (89).
Viruses
Herpesvirus, including human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) and
herpes simplex virus (HSV), have been detected in AP samples (90-95). It is proposed that
herpesviruses may increase the virulence of resident bacterial pathogens by enhancing bacterial
adherence and invasiveness (90, 91). In AP, the destruction of mammalian cells by herpesvirus
infection may facilitate the penetration of bacteria into connective tissue. Herpesvirus can inhibit
the expression of macrophage surface receptors that recognize components in the gram-negative
bacterial cell wall and prevent macrophages from destroying invasive bacteria (95, 96).
Table 2 shows the occurrence of herpesvirus infection in SAP and AAP and summaries of
the results. Most of the studies detected HCMV and EBV in more than 50% of SAP cases and it
was less detected in AAP cases (92, 93, 95, 97-103). In terms of coinfection, three studies detected
HCMV/EBV in more than 50% of SAP cases and it was less detected AAP cases (95, 100, 103).
Six studies reported coinfection of HCMV/EBV in less than 50% of SAP cases (93, 99, 101, 102,
104-106). Such discrepancies in the detection rates of HCMV and EBV in reported studies might
be attributed to different factors such as clinical status of the study subjects, viral diagnostic
methods used, geographic differences in herpes viral occurrence, presence of the viruses in latently
infected cells, different subtypes of EBV and HCMV (90, 94, 99, 107).
Herpesviruses may cause AP as a direct result of virus infection and replication which may
damage the host defense (91). The possibility that the bacterial infection process activates the
viruses has been proposed (107). It is hypothesized that AP may develop as a result of a series of
interactions among herpesviruses, bacteria, and host immune reactions (91). Indeed, SAP cases
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infected with EBV were more likely to be infected with Treponema denticola, Prevotella
intermedia, Aggregatibacter actinomycetemcomitans, and Porphyromonas gingivalis (104).
Sabeti et al. reported that herpesvirus species in cooperation with bacteria may play major roles in
SAP in humans (95). SAP was likely to occur in large-sized AP lesions than small lesions when
infected with EBV or HCMV and EBV (93, 97). The interactions between herpesvirus and bacteria
may explain the clinical symptoms of AP (103). For example, the absence of herpesvirus infection
or reactivation and the lack of pathogenic bacteria may explain the fact that some teeth with AP
can maintain periapical health or minimal disease for extended periods of time (91, 103).
Therefore, to prevent and treat AP a possible solution maybe the use of antiviral agents (sodium
hypochlorite and iodine) and vaccination against herpesviruses (91).
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Table 2 – Occurrence of virus infections in symptomatic (SAP) and asymptomatic (AAP) apical periodontitis: Epstein-Barr virus
(EBV), herpes simplex virus (HSV-1), human herpesvirus (HHV), and Varicella zoster virus (VZV).

SAP

AAP

Results

HCMV (71%), EBV
(42%), coinfection
HCMV/EBV (35.5%)
HCMV (100%) and
EBV (80%)
HCMV (15%), EBV
(43%), HSV-1 (15%),
VZV (0)
HCMV (92%), EBV
(61%), HSV (0%).

HCMV (24%), EBV
(0%), coinfection
HCMV/EBV (0%)
HCMV (14%) and EBV
(14%)
HCMV (16%), EBV
(45%), HSV-1 (9.68%),
VZV (0)
HCMV (7%), EBV (0%),
HSV (0%)

HCMV (53.6%), EBV
(3.6%), coinfection
HCMV/EBV (0%)
HCMV (62.5%), EBV
43.7%), coinfection
HCMV/EBV (25%)
HCMV (100%), EBV
(0%), coinfection
HCMV/EBV (76%),

HCMV (27.3%), EBV
(4.5%), coinfection
HCMV/EBV (4.5%)
HCMV (41.7%), EBV
(25%), coinfection
HCMV/EBV (16.7%)
HCMV (37%), EBV
(25%), coinfection
HCMV/EBV (26%),

HHV-6 (29%), EBV
(53%), HCMV (0%),
coinfection HHV6/ EBV
(23%), coinfection
HCMV/EBV (6%).

HHV-6 (13%), EBV
(47%), HCMV (4%),
coinfection HHV6/ EBV
(13%), coinfection
HCMV/EBV (9%).

HCMV/EBV (69%),
HCMV or EBV (30%),
neither HCMV nor EBV
(0%).
HCMV (55%), EBV
(88.9%), coinfection
HCMV/EBV (44%),

HCMV/EBV (36%),
HCMV or EBV (9%),
neither HCMV nor EBV
(54%).
HCMV (0%), EBV (0%),
coinfection HCMV/EBV
(0%),

Symptomatic manifestation was likely to
occur if a large-sized AP lesion is aggravated
with active EBV infection.
HCMV and EBV virus mRNA were mostly
detected in SAP than AAP.
No significant differences in the incidence of
HCMV, EBV, HSV-1, or VZV between the
SAP and AAP by DNA and RNA analyses.
HCMV and EBV occurred at higher frequency
in SAP showing radiographic bone
destruction.
HCMV was most frequent in SAP. Significant
differences were observed between SAP and
AAP.
The difference in occurrence of HCMV and
EBV DNA between SAP and AAP was not
statistically significant.
The difference in occurrence of HCMV and
EBV between SAP and AAP was statistically
significant. EBV may contribute to periapical
pathogenesis in a subset of SAP.
HHV-6 was significantly higher in SAP
samples than AAP samples (20% vs. 2.5%; P
= .03). HHV-6-B was significantly associated
with large-sized and symptomatic lesions.
EBV and HHV-6B infections can be
associated with SAP.
Higher occurrence of herpesvirus was detected
in large versus small periapical lesions and in
SAP.

HCMV (0%), EBV
(72%)

HCMV (0%), EBV (28%)

HCMV (15%), EBV
(70%), coinfection
HCMV/EBV (15%)
HCMV (58%), EBV
(67%), coinfection
HCMV/EBV (33%)
HCMV (100%), EBV
(100%), coinfection
HCMV/EBV (100%),

HCMV (0%), EBV (39%)

The difference in occurrence of HCMV and
EBV between SAP and AAP was statistically
significant. No viruses were detected in the
asymptomatic group.
Although there was an obvious association of
the virus with SAP and AAP, it is unlikely
that these viruses play a major role in the
pathogenesis of AP.
Association between EBV, specific bacterial
anaerobic infection, and SAP was found in
peri-implants.
HCMV and EBV play a putative role in the
pathogenesis of SAP in deciduous teeth.
HCMV and EBV participate in the
pathogenesis of SAP.

Ref
(93)
(92)
(94)
(97)
(98)
(99)

(100)

(105,
106)

(95)

(101)

(108)

(104)
(102)
(103)
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HCMV (23%), EBV
(31%), coinfection
HCMV/EBV (14%),

No significant difference was found when
comparing the prevalence of these two viruses
in AAP. HCMV was significantly more
frequent in AAP cases from HIV-positive
patients (67%) than in lesions from HIVnegative patients (8%).

(109)

17
Pain and inflammation
Expression of cytokines
Cytokines are proteins secreted by cells that mediate multiple immunologic, nonimmunologic biological function and have a specific effect on the interactions and
communications between cells (110, 111). Inflammatory cells such as, neutrophils, macrophages,
T lymphocytes, B lymphocytes, plasma cells, and dendritic cells are activated by the presence of
cytokines produced by surrounded cells (i.e. dental and bone cells and nerves) due to bacteria
endotoxin that reaches the apical region (112-120). T helper (Th) cells play an important role
producing cytokines exerting different functions. Th1 cells are characterized by production of
interferon-γ (IFN-γ), interleukins (IL-2, IL-11, IL-12) and TNF-α and are involved in the
progression of periapical lesions and bone destruction (121). Th2 cells secrete interleukins (IL-4,
IL-5, IL-6, IL-10, and IL-13) and together with transforming growth factor (TGF-β) mediate the
healing processes occurring in the late stage of AP development and down-regulation of the
inflammatory reaction (121). Table 3 shows studies of cytokines expression in AP and summaries
of the results.
Indeed, the synergistic interaction between cytokines, specifically IL-1, IL-6, TNF-α, IL-8
and IL-17, regulates the pathogenesis of AP in human (110, 122-124). Majority of the studies
reported higher level of cytokines in periapical lesions and significant differences were observed
between SAP and AAP (101, 110, 122-130). Gazivoda et al. studied the correlation between
proinflammatory and immunoregulatory cytokines in periapical lesions and their relationship with
cellular composition and clinical presentation (126). Large-size lesions showed lower percentages
of mononuclear phagocytes and produced higher levels of TNF-α, IL-6 and IL-10 compared with
small-size lesions (126). Martinho et al. reported that IL-6 and PGE2 were correlated with pain
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but not with size of the radiographic lesion, whereas IL-6 and TNF-α were positively correlated
with size of the radiographic lesion and exudate (131). Chronic AP may involve specific T- and
B-cell-mediated anti-bacterial responses and activate a network of regulatory cytokines which are
produced by Th1- and Th2-type T-lymphocytes (96, 121).
The mechanism of pain may be associated with the release of cytokines which induce the
trigeminal afferent neurons to express receptors, such as TLR4 and CD14 receptor complex, that
may trigger intracellular signaling cascades, leading to the peripheral release of neuropeptides and
central nociceptive neurotransmission (127). Other substance such as matrix metalloproteinases
(MMP-9) and monocyte chemotactic proteins (MCP) may be related to inflammation and
mechanisms of pain (127, 132). MMP-9 is essential for initiating the osteoclastic resorption and it
regulates neuropathic pain after peripheral nerve injury through degenerative and proinflammatory
mechanisms (127). MCP-3 is a chemokine that acts predominantly on macrophages, highly
expressed in chronic inflammatory disorders and bone resorption (132). Both MMP-9 and MCP3 were significantly expressed in SAP cases than AAP cases (127, 132). The presence of viruses
also correlates with the expression of cytokines in symptomatic periapical lesions (101, 102). It
has been suggested that HCMV and EBV infections in periapical lesions may explain various
pathological features of the inflammatory process (103). They may trigger the release of cytokines
from inflammatory cells, but the cause for differing periapical levels of these proinflammatory
mediators and bone resorption-stimulating molecules has not been established (103).
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Table 3 – Expression of cytokines in SAP and AAP. IL-interleukin; GM-CSF-granulocyte-macrophage colony-stimulating factor;
TNF-α - tumor necrosis factor-α; LTB4 – leukotriene B4; MMP - matrix metalloproteinase; Th - T helper; MCP-3 - monocyte
chemotactic protein-3; PGE2 - Prostaglandin E2; γIFN - Interferon gamma.

Expression of
Results

Ref

Higher levels of IL-6 and GM-CSF was found in symptomatic than in
asymptomatic lesions, but the difference was not significant.
Significantly higher IL-8 levels were found in SAP.

(133)

Higher level of IL-1β was found in SAP compared with AAP lesions,
but the difference was not significant.
Higher concentrations of LTB4 were found in SAP compared with
AAP.
There were no significant differences in TNF- α levels between SAP
and AAP. IL-6 levels were significantly higher in SAP than AAP.
Inflammatory cells from SAP secreted higher levels of IL-1, IL-6 and
IL-8 compared with asymptomatic lesions.
SAP showed statistically significant increased numbers of gramnegative bacteria and higher MMP-9 expression than the AAP.
SAP cases showed higher neutrophil elastase levels than AAP cases.

(116)

SAP cases showed high production of IL-17 than AAP cases.

(128)

No correlation was found between the levels of Th1 and Th2 cytokines
and symptoms.
MCP-3 levels were significantly higher in SAP than in AAP.

(121)

Higher levels of IL-1β in groups with clinical signs, but the differences
were not significant.
Predominance in symptomatic cases: high IL-6; intermediate to high
IL1B and low TNF-α.
There was a positive correlation between the levels of IL-17 and IL-8
in the group of symptomatic lesions.
IL-6 and PGE2 were correlated with pain but not with size of the
radiographic lesion.
RANKL expression showed significantly higher occurrence in
periapical pathosis than in healthy pulpal tissue. No relationship was
found between RANK and SAP and AAP.
There was a significant correlation between TNF, γ-IFN, IL-1, IL-12
and EBV, HCMV in SAP cases.
Highest concentrations of TNF-α were found in SAP and slightly less
in AAP.
A positive association was found between endotoxin and symptomatic
cases (e.g. spontaneous pain, tenderness to percussion, pain on
palpation, swelling and purulent exudates)

(135)

cytokines
IL-6, GM-CSF
IL-8
IL-1β
LTB4
TNF-α, IL-6
IL-1, IL-6, IL-8,
IL-10
MMP-9
Neutrophil
elastase
IL-17
Th1, Th2
MCP-3
TNF-α, IL-1β
CD14, TNF-α,
IL1β, IL6, IL10
Il-17, IL-8
TNF-α, IL1β, IL6,
IL10, PGE2
RANK
TNF-α, γ-IFN, IL1, and IL-12
TNF-α
Endotoxin

(122)

(125)
(123)
(126)
(127)
(134)

(132)

(129)
(130)
(124)
(102)
(101)
(110)
(136,
137)
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Bone resorption in periapical lesions
Bone resorption in the periapical region is one of the clinical hallmarks of periapical
pathosis. It is controlled by inflammatory and anti-inflammatory cytokines which influence the
differentiation of mononuclear cells into osteoclasts, or other cell lineages such as dendritic cells
and macrophages. Figure 4 shows the mechanisms of bone resorption by osteoclasts in AP (138,
139). Osteoclast activation by cytokines (TNF-α, IL-1 and IL-17) is mediated by the formation of
cyclooxygenase pathway products such as prostaglandins (138, 139). Nuclear factor kappa B (NFkB)–ligand (RANKL) induces bone resorption, whereas osteoprotegerin (OPG) acts to neutralize
these effects. RANKL messenger RNA expression is significantly higher in periapical lesions
(140-142).

Figure 4. Bone resorption by osteoclasts in AP. DC, Dendritic cell; HSC,
hematopoietic stem cell; Mφ, macrophage; MSC, mesenchymal stromal cell; Nφ,
neutrophil; OB, osteoblast; OC, osteoclast; OCP, osteoclast precursor; OPG,
osteoprotegerin; RANK, receptor activator of nuclear factor κB; RANKL,
receptor activator of nuclear factor κB ligand. (21)
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Animal models of AP
Studying AP in humans has some significant limitations such as their cross-sectional
nature, restricted ethical reasons, and only association with symptoms instead of a cause-and-effect
relationship can be inferred. The development of AP has been elucidated using animal models by
dental pulp exposure. The animal is anesthetized, and the pulp is exposed for several days to the
oral environment or inoculated with bacterial species associated with human endodontic infections
(143). The progression of the disease is confirmed radiographically by the presence of periapical
radiolucency. The use of advanced analysis techniques and genetically engineered animals such
as mice and rats have been useful to clarify the etiopathology of this condition, improve diagnosis,
and search for new therapeutic options.
Expression of cytokines in animal models
AP has been studied in different animal models (Table 4). In mice and rats, cytokines were
expressed after 2 days pulp exposure and periapical lesion were observed between induction on
day 0 and day 15 ("active phase"), increasing the lesion at a slower rate at days 20 and 30 ("chronic
phase") (139, 143, 144). IL-1α and TNF-α were highly expressed at day 7 and increased at day
28, while IL-6 increased at day 14 and then declined (145). Th1-type cytokines (IL-2, IL-12, and
IFNγ) showed an increase expression in periapical lesions, while the expression of Th2-type
cytokines (IL-4, IL-6, IL-10, IL-13) was similarly increased, but they declined at the latest at day
28, suggesting possible inhibition by Th1-type mediators. This evidence indicates that a cytokine
network is activated in response to bacterial infection, and that Th1-modulated pro-inflammatory
pathways may predominate during periapical bone destruction (145). Similar results were reported
in a rat model of AP, where bone resorption stimulated by bacterial infection was primarily
mediated by IL-1α (139). In another study, AP in mice progressively increased the number of
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osteoclasts and cementoclast, and the mRNA levels of RANK, RANKL, and Cathepsin K (CatK)
after 7, 21, and 42 days pulp exposure. The endotoxin from bacteria bind to their specific receptors
in immune cells (monocytes, macrophages and neutrophils) and activates intracellular pathways
(i.e. transcriptional factor NF-κβ) which upregulates pro-inflammatory cytokines promoting bone
resorption (146-148). It was reported that cytolytic E. faecalis strain induced local IL-1β and
MMP-8 expression causing severe local inflammation and tissue destruction in persistent AP in
rats (149). Indeed, MMPs (MMP-2 and MMP-9) play a critical role in the development of
inflammatory AP by degrading the extracellular matrix (149, 150).
AP elevated the levels of C-reactive protein, IL-2, and IL-6 in rat blood serum, causing
reversible changes in the aortic arch, myocardium, spleen and in the liver (151). Therefore, AP
contributes to the systemic immune response, which is not confined to the localized lesion, and
can potentially trigger an increase in systemic inflammation impairing remote organs and affecting
the general health of patients (147, 151). In another study, pregnant rats with AP had a significantly
longer pregnancy and delivered pups with a significantly higher birthweight. They had
significantly higher concentrations of IL-6, VEGF, IL-1β, and IL-10 within the uterine horn and
IL-6, CRP and TNF-α within the liver (152). Furthermore, this study suggests that animals with
induced AP developed insulin resistance, which significantly affected their pregnancy outcomes.
Some diseases, such as diabetes, can enhance the development of AP (153, 154).
Animals models of AP have also been used to elucidate the mechanisms of inflammatory
pain. The dental pulp and periradicular tissues are innervated by nociceptive neurons which release
neuropeptides such as calcitonin gene-related peptide (CGRP) (155). Rat capsaicin-treated with
induced AP showed a significant depletion of susceptible neurons and CGRP in the dental pulp,
reveling a protective effect of the neurons in the initial phase of AP (155). Tarsa et al. demonstrated
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that brain-derived neurotrophic factor (BDNF) is significantly upregulated in transient receptor
potential vanilloid type 1 (TRPV1) immunoreactive (IR) neurons in both rats and mice, and CGRPIR neurons in mice, but not rats. The inflammation-induced upregulation of BDNF is stronger in
mice compared to rats (156).
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Table 4 – Animal models to study the development of AP. CGRP- Calcitonin gene-related peptide; CRP- C-reactive protein;
RANK - receptor activator of nuclear factor kappa-B; RANKL - receptor activator of the nuclear factor kappa-B ligand; OPG –
osteoprotegerin; 5-LO - 5-lipoxigenase; MIF - migration inhibitory factor; VEGFs - Vascular endothelial growth factors;
VEGFRs - Vascular endothelial growth factors receptors; CIITA - class II transactivator, SAA - serum amyloid A; BDNF - brainderived neurotrophic factor; Cyr61 - Cysteine Rich Angiogenic Inducer 61; MMP - matrix metalloproteinase.

Animal
Effect

Results

Ref.

Feline
immunodeficiency
virus (FIV)
Open versus sealed
canals

IL-1β production decreased in the FIV group. In the non-FIV group, IL-1β
decreases at the chronic stage of the AP compared with the acute stage.

(157)

model
Cat
Dog
Dog

SAA, CRP

Dog

Pulp exposure and
coronal sealing

Ferrets

Periapical lesion

Mice

Mice

RANK, RANKL,
OPG, and
cathepsin K
IL-1α, TNF-α, IL6, IL-11], IL-2, IL12, IFNγ, IL-4, IL6, IL-10, IL-13

Mice

IL-9 and IL-22

Mice

IL-1β, TNF-α,
RANK, MCP-1
RANKL,

Mice

IL-6

Mice

IL-10, IL-4

Mice/
Rat

BDNF

Rat

Bone resorbing

Rat

IL-1α, TNF-α

Rat

IL-1α, TNF-α

Rat

Odontogenic cysts

Rat

Root canal
treatment

Rat

Lipopolysaccharide
(LPS)

Induced AP inflammatory lesions by oral exposure, followed by tooth
sealing, produced root canal microbiota similar to that found in humans.
Canine model provides a useful means for studying the systemic effects of
AP, and it is not associated with elevated CRP or SAA.
There was no histopathological difference among induced AP in the teeth
with coronal sealing.
AP was visible in all teeth within 4 weeks. The induced lesions consisted
principally of a mononuclear inflammatory infiltrate, dominated by
macrophages but with numerous lymphocytes.
Cementocytes express RANKL in response to endodontic infection in AP.
A cytokine network is activated in the periapex in response to bacterial
infection, and that Th1-modulated pro-inflammatory pathways may
predominate during periapical bone destruction.
Increasing levels of IL-9 and IL-22 mRNA were detected in AP, and
inverse correlations were found between IL-9 and IL-22 and the increase
of lesion area in the different time point intervals.
Nitric oxide, but not reactive oxygen species, controls expression of
cytokines and progression of bone resorption in AP.
IL-6-/- mice developed AP more rapidly than IL-6+/+ mice.
IL-10, but not IL-4, is an important endogenous suppressor of infectionstimulated bone resorption in vivo, likely acting via inhibition of IL-1α
expression.
Mouse TG provides a suitable model to study molecular mechanisms of
inflammation-dependent regulation of BDNF expression in vivo.
Bone-resorbing activity is temporarily related to periapical bone
destruction in AP rat model.
IL-1α plays a key role in the pathogenesis of AP in the rat mode.
Bone resorption stimulated by bacterial infection is primarily mediated by
IL-1α in AP rat model.
Inflammatory stimulation from the apices can cause cystic changes in the
enamel epithelium of underlying teeth.
AP model using rats can be used in developmental research for novel
methods of root canal treatment.
Induced AP in animal model by exposing pulps and placing LPS, and
exposing to the oral environment is similar to human natural progress of
the same disease and has a shorter time duration.

(158)
(159)
(160)
(148)
(161)

(145)

(162)
(163)
(164)
(165)
(156)
(144)
(143)
(139)
(166)
(167)
(168)
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Rat

CGRP

Rat

CRP, IL-2, and IL6

Rat

IL-1β. IL-1α

Rat

Sirtuin 6

Rat

IL-1β and MMP-8

Rat

Sympathetic
nerves, IL-1α,
TNF-α

Rat

IL-17

Rat

MIF, RANK,
RANKL

Rat

VEGFs, VEGFRs

Rat

CIITA, TNF-α,
Cyr61

Rat

Pregnancy

Rat

CD14, TLR4

Rat

MMP-2, MMP-9

Rat

Diabetes

Rat

Streptozotocininduce diabetic

Capsaicin-sensitive neurons has a protective effect in the initial phase of
AP.
AP elevated the levels of CRP, IL-2, and IL-6 in rat blood serum, causing
reversible changes in the aortic arch, myocardium, and spleen as well as
irreversible changes in the liver.
203 genes were up-regulated to more than 5-fold (IL-1β. IL-1α), and 864
genes were down-regulated to less than 20% of baseline level (e.g.,
caspase 8) in inflammation phase of AP.
Development of AP in rats was associated with decreased expression of
SIRT6 and increased glycolysis and apoptosis in osteoblasts.
IL-1β expression enhancement occurred during the early phase of
infection, whereas increased MMP-8 expression lasted for a prolonged
period.
Sympathetic nerves have an inhibitory effect on IL-1 α in AP and a
stimulatory effect on TNF- α in the intact rat pulp.
The combination of AP and periodontal disease increased the serum IL-17
levels in diabetes and normoglycemic rats and increased the neutrophil
levels in diabetes rats. Diabetes increased the neutrophil levels and bone
resorption in rats.
These findings showed that MIF might be associated with the
differentiation of osteoclasts in AP. MIF contributes to the pathogenesis of
the AP through the induction of RANKL protein.
VEGF family and receptors are involved in vascular remodeling and
immune functions during AP development.
CIITA might play a protective role in the pathogenesis of bone resorption
in AP, possibly through down-regulating the expression of Cyr61 in
osteoblasts.
Blood glucose and serum TNF-α, IL-6, endothelin-1, IL-10, and insulin
concentrations were significantly higher in the pregnant animals with AP.
CD14 and TLR4 may play important roles in the pathogenesis of AP,
probably via immune cells such as monocytes/macrophages and
neutrophils.
MMP-2 and MMP-9 play critical roles in the development of inflammatory
AP, probably involved in the extracellular matrix (ECM) degradation
during the initial phase of the lesion development.
The metabolic conditions produced by type 2 diabetes enhance the
development of AP in rats.
Inflammation and root resorption and alveolar bone resorption were more
severe in streptozotocin-induced diabetic rats than that in control rats.

(155)
(151)
(169)
(170)
(149)
(171)

(7)

(172)
(173)
(174)
(152)
(146)
(150)
(153)
(154)
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Treatment of AP in animal models
Although the success rate of endodontic treatment for AP is approximately 80%, there is
still an urgent need for increased efficacy of treatment (175). Table 5 shows a list of possible
molecules for the treatment of AP. For instance, odanacatib, dexamethasone, simvastatin, tempol,
tactivin, polymyxin B, osteopontin, epigallocatechin-3-gallate and bisphosphonates prevented the
AP development in mice and rat models (7, 176-184). In the case of simvastatin molecule, it
attenuated bone resorption, reduced osteoblastic expressions of cysteine rich angiogenic inducer
61 (Cyr61), transcription factor p-FoxO3a, and chemokine CCL2, and suppressed macrophage
recruitment (177, 180). Atp6i RNAi can ameliorate the development of endodontic disease by
reducing bone resorption and inflammation (175).
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Table 5. Animal models to study the treatment of AP

Animal
Effect

Results

Ref.

Feline
immunodeficiency
virus (FIV)
Open versus sealed
canals

IL-1β production decreased in the FIV group. In the non-FIV group, IL-1β
decreases at the chronic stage of the AP compared with the acute stage.

(157)

model
Cat
Dog
Dog

SAA, CRP

Dog

Pulp exposure and
coronal sealing

Ferrets

Periapical lesion

Mice

Mice

RANK, RANKL,
OPG, and
cathepsin K
IL-1α, TNF-α, IL6, IL-11], IL-2, IL12, IFNγ, IL-4, IL6, IL-10, IL-13

Mice

IL-9 and IL-22

Mice

IL-1β, TNF-α,
RANK, MCP-1
RANKL,

Mice

IL-6

Mice

IL-10, IL-4

Mice/
Rat

BDNF

Rat

Bone resorbing

Rat

IL-1α, TNF-α

Rat

IL-1α, TNF-α

Rat

Odontogenic cysts

Rat

Root canal
treatment

Rat

Lipopolysaccharide
(LPS)

Rat

CGRP

Induced AP inflammatory lesions by oral exposure, followed by tooth
sealing, produced root canal microbiota similar to that found in humans.
Canine model provides a useful means for studying the systemic effects of
AP, and it is not associated with elevated CRP or SAA.
There was no histopathological difference among induced AP in the teeth
with coronal sealing.
AP was visible in all teeth within 4 weeks. The induced lesions consisted
principally of a mononuclear inflammatory infiltrate, dominated by
macrophages but with numerous lymphocytes.
Cementocytes express RANKL in response to endodontic infection in AP.
A cytokine network is activated in the periapex in response to bacterial
infection, and that Th1-modulated pro-inflammatory pathways may
predominate during periapical bone destruction.
Increasing levels of IL-9 and IL-22 mRNA were detected in AP, and
inverse correlations were found between IL-9 and IL-22 and the increase
of lesion area in the different time point intervals.
Nitric oxide, but not reactive oxygen species, controls expression of
cytokines and progression of bone resorption in AP.
IL-6-/- mice developed AP more rapidly than IL-6+/+ mice.
IL-10, but not IL-4, is an important endogenous suppressor of infectionstimulated bone resorption in vivo, likely acting via inhibition of IL-1α
expression.
Mouse TG provides a suitable model to study molecular mechanisms of
inflammation-dependent regulation of BDNF expression in vivo.
Bone-resorbing activity is temporarily related to periapical bone
destruction in AP rat model.
IL-1α plays a key role in the pathogenesis of AP in the rat mode.
Bone resorption stimulated by bacterial infection is primarily mediated by
IL-1α in AP rat model.
Inflammatory stimulation from the apices can cause cystic changes in the
enamel epithelium of underlying teeth.
AP model using rats can be used in developmental research for novel
methods of root canal treatment.
Induced AP in animal model by exposing pulps and placing LPS, and
exposing to the oral environment is similar to human natural progress of
the same disease and has a shorter time duration.
Capsaicin-sensitive neurons has a protective effect in the initial phase of
AP.

(158)
(159)
(160)
(148)
(161)

(145)

(162)
(163)
(164)
(165)
(156)
(144)
(143)
(139)
(166)
(167)
(168)
(155)
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Rat

CRP, IL-2, and IL6

Rat

IL-1β. IL-1α

Rat

Sirtuin 6

Rat

IL-1β and MMP-8

Rat

Sympathetic
nerves, IL-1α,
TNF-α

Rat

IL-17

Rat

MIF, RANK,
RANKL

Rat

VEGFs, VEGFRs

Rat

CIITA, TNF-α,
Cyr61

Rat

Pregnancy

Rat

CD14, TLR4

Rat

MMP-2, MMP-9

Rat

Diabetes

Rat

Streptozotocininduce diabetic

AP elevated the levels of CRP, IL-2, and IL-6 in rat blood serum, causing
reversible changes in the aortic arch, myocardium, and spleen as well as
irreversible changes in the liver.
203 genes were up-regulated to more than 5-fold (IL-1β. IL-1α), and 864
genes were down-regulated to less than 20% of baseline level (e.g.,
caspase 8) in inflammation phase of AP.
Development of AP in rats was associated with decreased expression of
SIRT6 and increased glycolysis and apoptosis in osteoblasts.
IL-1β expression enhancement occurred during the early phase of
infection, whereas increased MMP-8 expression lasted for a prolonged
period.
Sympathetic nerves have an inhibitory effect on IL-1 α in AP and a
stimulatory effect on TNF- α in the intact rat pulp.
The combination of AP and periodontal disease increased the serum IL-17
levels in diabetes and normoglycemic rats and increased the neutrophil
levels in diabetes rats. Diabetes increased the neutrophil levels and bone
resorption in rats.
These findings showed that MIF might be associated with the
differentiation of osteoclasts in AP. MIF contributes to the pathogenesis of
the AP through the induction of RANKL protein.
VEGF family and receptors are involved in vascular remodeling and
immune functions during AP development.
CIITA might play a protective role in the pathogenesis of bone resorption
in AP, possibly through down-regulating the expression of Cyr61 in
osteoblasts.
Blood glucose and serum TNF-α, IL-6, endothelin-1, IL-10, and insulin
concentrations were significantly higher in the pregnant animals with AP.
CD14 and TLR4 may play important roles in the pathogenesis of AP,
probably via immune cells such as monocytes/macrophages and
neutrophils.
MMP-2 and MMP-9 play critical roles in the development of inflammatory
AP, probably involved in the extracellular matrix (ECM) degradation
during the initial phase of the lesion development.
The metabolic conditions produced by type 2 diabetes enhance the
development of AP in rats.
Inflammation and root resorption and alveolar bone resorption were more
severe in streptozotocin-induced diabetic rats than that in control rats.

(151)
(169)
(170)
(149)
(171)

(7)

(172)
(173)
(174)
(152)
(146)
(150)
(153)
(154)
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In this study, we aim to examine the development of AP in CBM mice. This study is
significant in the following aspects:
1. Examine periapical bone loss and inflammation levels in CBM mice after pulp
exposure.
2. Investigate if increased host inflammatory response in CBM mice exacerbates AP.
So far, there is no study on how AP develops in CBM. Since CBM mice and patients have
increased inflammatory response, we ask whether AP develops differently compared to healthy
subjects.
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Chapter II: Research aims and hypothesis
Research aim
Development and characterization of AP in CBM mice

Hypothesis
AP may be exacerbated by the increased host inflammatory response in CBM mice.
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Chapter III: Materials and Methods
Mice
CBM mouse model was generated as described on the previous study (4). Briefly, prolineto-arginine (P416R) missense mutation in exon 9 of murine SH3BP2 was induced using a targeting
construct containing a 20 kb gene fragment, a Neo-cassette flanked by loxP sites inserted between
exons 8 and 9, a mutated exon 9, and a thymidine kinase cassette at the 3’ end. Mice were crossed
with a cre-deleter strain to remove the Neo cassette in the SH3BP2 gene. Then, mice carrying
SH3BP2 knock-in (KI) alleles were backcrossed to C57BL6/J mice. All animals were housed in
specific pathogen free facilities and monitored carefully, following strict guidelines for humane
care and treatment of animals. For this study, the experiments were carried out on 8-wk-old
sh3bp2+/+, sh3bp2+/KI and sh3bp2KI/KI male and female mice. Mice were housed in small unisex
groups in a temperature-controlled room (22–24 °C) on a 12 h light/dark cycle, with access to food
and water ad libitum. The animal protocol (101297-0119) was approved by the Center of
Comparative Medicine at the University of Connecticut Health.
For genotyping of wild-type and mutant animals, PCR with primers (P1 and P2) from
within intron 8 of the SH3BP2 gene was used. The sequences of these primers are: P1 (sense): 5’
CCACTATATGACAATACCTG 3’; P2 (antisense): 5’ CATAGTCTTCATCTGAGTCC 3’. For
sequencing the SH3BP2 gene in wild-type, heterozygous and homozygous mutants, DNA was
isolated from mouse tail. The genotyping was performed before mouse weaning and after each
time point.
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Figure 5. Schematic view of Materials and Methods

Periapical lesion induction
Induction of periapical lesions was performed as described previously (185). Briefly, the
mice were anesthetized by an intraperitoneal injection of ketamine/xylazine (ketamine 100-120
mg/kg, xylazine 5-10 mg/kg). Mice were then mounted on a jaw retraction board. Access to the
pulp chamber of the mandibular right first molars was gained with stainless-steel #1/4 round burs
(Brasseler USA, Savannah, GA) in a low-speed handpiece under the microscope and fiber light
(Fiber-Lite® Mi-LED, Dolan-Jenner, MA, USA). Canals were localized and explored with a 23/6
explorer (Hu-Friedy USA, Chicago, IL) and left exposed to the oral cavity for lesion induction.
Left side mandibles were used as control. Mice with or without pulp exposure were subjected to
weight measurement after 1, 3, 6, 9, 13, 17 and 21 days. They were sacrificed after each time point
in a CO2 chamber as demonstrated in the Figure 5. Percentage of weight change normalized to day
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0 over 21 days was determined. Here we only included date from male mice. The following group
of mice were used: at day 3 (sh3bp2+/+ n= 6, sh3bp2+/KI n=5, sh3bp2KI/KI n =5), 7 (sh3bp2+/+ n =6,
sh3bp2+/KI n =3, sh3bp2KI/KI n =4), 14 (sh3bp2+/+n=3, sh3bp2+/KI n=3, sh3bp2KI/KI n=3) and 21
(sh3bp2+/+ n=5, sh3bp2+/KI n=3, sh3bp2KI/KI n=4).

Faxitron x-ray and micro-CT analysis
Both left and right mandibles were dissected and attached muscle was grossly removed.
Mandibles were fixed in 4% paraformaldehyde (PFA) (EMS, Hatfield, PA, USA) for 48 hours.
Samples were radiographically imaged using a Faxitron™ (Faxitron Bioptics, Tucson, AZ, USA)
with the exposure time of 3 seconds and voltage of 26 kV at days 3, 7, 14 and 21. High resolution
micro–computed tomography (micro-CT) scans (Scanco µCT 40, Scanco Medical, AG,
Bassersdorf, Switzerland) were obtained on right and left mandibles of sh3bp2+/+, sh3bp2+/KI and
sh3bp2KI/KI male mice (n=3 for each group) 21 days after pulp exposure. Serial images were
acquired transverse to the longitudinal axis of the hemimandible at 55 kVp (145 µA), employing
1000 cone-beam projections per revolution at an integration time of 300 ms within a 12.3 mm field
of view. Three-dimensional image arrays were reconstructed using standard convolution backprojection algorithms with Shepp and Logan filtering, and rendered at an isometric spatial
resolution of 12 µm voxels.

Hematoxylin staining and immunohistochemical analysis
For hematoxylin staining and immunohistochemical (IHC) analysis, mandibles were fixed
and demineralized in 14% ethylenediaminetetraacetic acid (EDTA) which was changed every 3
days for 20 days at 4°C. Once decalcified, the dissected mandibles were processed according to
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the Table 6. Then, they were embedded in paraffin (15×15×5 mold blocks) and serial sections of
6µm were prepared from the blocks using Leica RM2125 RT (Leica Biosystems Inc. IL, USA).
Sections were deparaffinized in xylene (2×5 min) and then hydrated serial ethanol dilution
(100, 95, 75 and 50%) for 2 min each. After rinsing in distilled water, sections were treated with
citrate buffer pH 6.0 at 60°C water bath overnight for a heat mediated antigen retrieval. Samples
were washed in PBS-1% Tween 20 three times wash, 5 minutes each time, and then, they were
incubated with 2.5% normal goat serum for 30 min at RT. Samples were incubated with primary
antibody anti-mouse CatK (SC-48353, Santa Cruz Biotechnology, Santa Cruz, CA, USA) at the
dilution of 1:50 (1% BSA-PBS) for 2 hours at room temperature for osteoclast staining. After
rinsing three times wash, 5 minutes each time, with PBS, peroxidase activity was blocked with 3%
H2O2 for 10 minutes at room temperature followed by three times wash, 5 minutes each time, with
PBS. Next, they were incubated with secondary antibody goat anti-mouse IgG-HRP (Pierce 32230,
Thermo Fisher Scientific, Waltham, MA, USA) for 1 hour at room temperature followed by three
times wash, 5 minutes each time, with PBS. Color was developed using chromogen/substrate in
DAB (5ml distilled water, 2 drops/84µl buffer, 4 drops/100µl DAB, 2 drops/80µl HPS) for 3
minutes. After washing with PBS twice, samples were counterstained with haematoxylin for 10
seconds before dehydration (95% ethanol for 2 min, 100% ethanol for 2×3 min), clearing (xylene
for 2×5 min) and mounting with SP15-100 Permount™ Mounting Medium (Fisher Scientific,
Hampton, NH, USA). The sections were scanned under the Axio Imager.Z1 microscope (Carl
Zeiss MicroImaging GmbH, Göttingen, Germany) coupled to an AxioCam MRm camera (Carl
Zeiss MicroImaging GmbH).
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Table 6 Paraffin embedding protocol

Station Hours:Min.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

1:00
1:00
1:00
0:15
0:15
0:01
0:20
0:20
0:20
0:20
0:20
0:20
0:20
0:20
0:20
0:20
0:20
0:20
0:10
0:10
0:10
0:10
overnight
1:00
1:00
1:00

Reagent
PBS
PBS
PBS
NaCl
NaCl/50% Ethanol
50% Ethanol
50% Ethanol
50% Ethanol
50% Ethanol
70% Ethanol
70% Ethanol
70% Ethanol
95% Ethanol
95% Ethanol
95% Ethanol
100% Ethanol
100% Ethanol
100% Ethanol
Ethanol:Xylene 1:1
Xylene
Xylene
Xylene
1:1 Xylene/Paraffin
Paraffin
Paraffin
Paraffin
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Quantitative analysis of osteoclast numbers
The analysis was performed in the same stained sections using the microscope at ×10
magnification operating in the bright field mode. After capturing the area, CatK(+) osteoclasts
area, numbers and the bone perimeter around the periapical of mandibular first molar were

A

B

Figure 6. The ratio of Cat-K+ area to the bone perimeters (A) and number of CatK(+) cells (B) around the periapex of first
molar were measured by Digimizer software.

measured as described (186, 187) using Digimizer Image Analysis software (MedCalc Software
bvba, Ostend, Belgium) as shown in Figure 6.

Statistical analysis
The results for weight change, CatK(+) cell numbers and the ratio of the CatK(+) area to
the periapical bone perimeter were analyzed using GraphPad Prism 5.0 (GraphPad Software, Inc.,
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La Jolla, CA, USA). Comparisons among multiple experimental groups over time were performed
by two-way ANOVA.
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Chapter IV: Results
Effect of AP on weight loss
In this study, dental pulp exposure method was used to induce AP in CBM mouse model.
Experimental sh3bp2KI/KI mice showed significant body weight loss on days 6, 13, 17 and 21
compared to that of sh3bp2+/+ and sh3bp2+/KI (P value < 0.05). Sh3bp2+/+ and sh3bp2+/KI mice
recovered their weight after 7 days. However, sh3bp2KI/KI mice continued to lose weight until 21
days after pulp exposure, suggesting pulp exposure leads to initial weight loss (Figure 7A). In
control mice without infection, sh3bp2+/+ and sh3bp2+/KI mice gained weight for 21 days, whereas,
sh3bp2KI/KI mice started losing weight at day 9 however the amount of weight loss was
significantly more in sh3bp2KI/KI mice receiving dental procedures (Figure 7B).
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*

*

*

*
*

*

A

B

*

Figure 7. Percentage (%) of body weight normalized to day 0 over 21 days in experimental (A) and control (B) groups.
sh3bp2KI/KI mice lost body weight until 21 days after pulp exposure.
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Radiographs of periapical lesions
The successful pulp exposure of each molar was validated by Faxitron radiography.
Periapical radiolucency is the radiographic sign of inflammatory bone lesions in the apical of the
tooth. We determined the prevalence of periapical radiolucency in CBM mice over time.
Radiographs of mandibles showed noticeable periapical radiolucency in the sh3bp2+/KI and
sh3bp2KI/KI mice after 3 days of pulp exposure (Figure 8). Whereas, sh3bp2+/+ showed no evident
radiolucency at day 3. Sh3bp2+/KI mice showed a consistent intermediate phenotype through all
assays and all time points. Left 1st molars without pulp exposure from the same mice showed no
periapical radiolucency.
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Control (Left)

Infection (Right)

Sh3bp2+/+

Sh3bp2+/KI

Sh3bp2KI/KI

Figure 8. Representative radiographs of mandibles after 3 days of pulp exposure showing noticeable periapical
radiolucency in the sh3bp2+/KI and sh3bp2KI/KI mice as indicated by arrows. Left side mandibles were used as control.

Figure 9 shows the progression of periapical bone destruction from day 7 to day 21. In
sh3bp2+/+ and sh3bp2+/KI mice, periapical radiolucency developed over time. sh3bp2KI/KI mice
showed periapical lesions in all time points and lesions were most severe at day 14. No periapical
lesions were observed in the controls.
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Day 7

Day 14

Day 21

Sh3bp2+/+

Sh3bp2+/KI

Sh3bp2KI/KI

Figure 9. Representative radiographs showing the progression of periapical bone destruction from day 7 to day 21.

Micro-CT images of periapical bone loss
Micro-CT, a high-resolution imaging modality, was used to analyze the bone resorption
progression after pulp exposure in CBM mice. Figure 10 shows the micro-CT images of mandibles
after 21 days pulp exposure. The results showed that significantly more bone destructions in
periapical areas of sh3bp2+/KI and sh3bp2KI/KI mice compared to the sh3bp2+/+ littermates, which
was more confined and limited to the periapex. No bone loss in the periapical area was observed
in control molars.
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Control M

Control D

Infected M

Infected D

Sh3bp2+/+

Sh3bp2+/KI

Sh3bp2KI/KI

Figure 10. Representative micro-CT images from controls and experimental groups after 21 days of pulp exposure.

Histologic sections of periapical inflammation
Representative paraffin-embedded sections were stained with CatK immunohistochemistry
followed by hematoxylin for a descriptive analysis of the pulp tissue and apical and periapical
regions under light microscopy and for the determination of the periapical lesion size. Figure 11A
shows CatK IHC staining in control molar sections. Before pulp exposure, molars have vital pulp
tissues with no obvious inflammation in all three groups. Three days after pulp exposure, the
inflammation was obvious in root canals and part of periapical area of sh3bp2KI/KI mice. Sh3bp2+/KI

44
mice showed intermediate phenotype. Pulp necrosis progressed more rapidly in sh3bp2KI/KI mice
compared to sh3bp2+/+ and sh3bp2+/KI mice (Figure 11B).

Sh3bp2+/+

Sh3bp2+/KI

Sh3bp2KI/KI

A

B

Figure 11.(A): Representative IHC/H CatK staining of control molar sections showing that all molars have vital pulp tissues with
no obvious inflammation. Red arrows show bone marrow cavity. (B): The inflammation is apparent in right 1st molars’ sections 3
days after pulp exposure stained by CatK followed by H&E. The inflammation is apparent in sh3bp2KI/KI samples.
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In sh3bp2KI/KI mice, the necrosis process of dental pulp seemed to occur at day 3 after the
coronal opening, whereas more dental pulp remained vital in sh3bp2+/+ mice. The disease
progressed more rapidly in sh3bp2KI/KI mice than sh3bp2+/KI and sh3bp2+/+ mice. The apical area
showed severely bone resorption and presence of osteoclasts on the alveolar bone, with generalized
edema and scattered inflammatory cells in sh3bp2KI/KI mice (Figure 12A). Inflammatory cell
infiltration significantly increased in the periapical tissues of sh3bp2KI/KI mice, while normal
periapical tissue was observed in sh3bp2+/+ mice (Figure 12B).
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Sh3bp2+/+ (day 3)

Sh3bp2KI/KI (day 3)

Necro
tic pu
lp

Vita

l pu

lp ti

ssue

A

B

Figure 12. Representative magnified images of pulpal tissues (A) and periapical tissues (B) after 3 days pulp exposure in sh3bp2+/+
and sh3bp2KI/KI
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At 14 days of pulp exposure, evident necrosis of the entire pulp tissue and a variable
amount of necrotic pulp rests were found in the root canals in all groups (Figure 13A). Moreover,
the apical cementum surface was irregular and presented resorption lacunae either empty or with
necrotic pulp rests. Expansion of the mandibles with root resorption and increased CatK(+) cells
were observed in sh3bp2KI/KI mice. CatK(+) osteoclasts were found on the surface of resorbed
roots (Figure 14). This result is interesting because root resorption is one of typical features of
CBM patients.

Sh3bp2+/+

Sh3bp2+/KI

Sh3bp2KI/KI
Root resorption

Figure 13. Expansion of the mandible with root resorption and increased Cat-K+ cells in sh3bp2KI/KI mice.
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Figure 14. CatK(+) osteoclasts were found on the surface of resorbed roots in sh3bp2KI/KI mice

Regarding periapical inflammation, inflammatory cells were confined in the periapical area
in sh3bp2+/+ mice, whereas sh3bp2KI/KI mice showed spreading and increased inflammatory cells
and bone resorption with no boundary (Figure 15A). Significant loss of furcal bone with increased
CatK(+) cells were also observed in furcation area of sh3bp2KI/KI mice compared to the sh3bp2+/+
mice (Figure 15B).
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Sh3bp2+/+ (day 14)

Sh3bp2KI/KI (day 14)

A

B

Figure 15. Periapical area (A) and furcation (B) of in sh3bp2+/+ and sh3bp2KI/KI 14 days after pulp exposure
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Quantitative analysis of osteoclast numbers
Data related to the ratio of CatK(+) area/bone perimeter and number of CatK(+) cells are
presented in Figure 16A and B. sh3bp2KI/KI mice showed higher percentage of CatK(+) area/ bone
perimeter on days 7 and 14 compared to other groups (Figure 16A). Also, sh3bp2KI/KI mice showed
higher percentage of CatK(+) numbers on days 7 and 14 compared to other groups (Figure 16B).

A

B

Figure 16. Distribution of CatK(+) in the periapical area over time: (A) Ratio of CatK area per bone perimeter around the
periapical of the mandibular first molar after pulp exposure (B): Number of CatK(+) cells around the periapical of the
mandibular first molar after pulp exposure.
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Chapter V: Discussion
CBM causes increased inflammatory bone loss in jawbones leading to premature
exfoliation of the primary and permanent dentition (15). In heathy bone tissue, the mineralized
bone is removed by osteoclasts followed by the formation of bone matrix from the osteoblasts that
subsequently become mineralized. The remodeling cycle consists of three phases: i) resorption
(osteoclasts digest old bone); ii) reversal (mononuclear cells appear on the bone surface); and iii)
formation (osteoblasts lay down new bone and the resorbed bone is replaced) (188). In the jaw,
this process serves to adjust the alveolar bone architecture to meet the mechanical needs and to
repair damages. Local bone remodeling involves different mediators such as cytokines and growth
factors (145, 188). The RANK, RANKL, and OPG play important roles in the regulation of bone
resorption and formation (188). In milder CBM cases, enlargement of the jaw continues throughout
childhood and stabilizes during puberty, and the abnormal growths are gradually replaced with
normal bone in early adulthood. Cytokines and the hypersensitivity of myeloid cells trigger a selfsustaining loop of TNF-α expression that leads to osteoclastogenesis and soft fibrous tissue
formation (4). In this study, we tested the hypotheses that AP may exacerbate host inflammatory
response in CBM mice. The results show that dental pulp exposure resulted in AP as early as at
day 3 in sh3bp2KI/KI mice and continuous weight loss over time. Moreover, inflammatory bone
resorption was more severe in sh3bp2KI/KI mice.
It has been suggested that SH3BP2 is a positive regulatory adaptor of inflammatory cells
(T cells, B cells, and NK cells) that produce factors that induce osteoclastic differentiation and
promote inflammation (189, 190). Ueki et al., reported that in vivo phenotypes (i.e. loss of alveolar
and cortical bone, inflammatory tissue infiltration, and lymph node abnormalities) was more
severe in homozygous CBM mice in comparison to heterozygous littermates (4). This difference
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is in part due to increased expression of serum TNF-α which was only increased in homozygous
mutants. TNF-α is known to induce RANKL expression and stimulates formation of osteoclast
progenitors (4, 191). Also, TNF-α gene promoter is known to contain several NF-κB-like motifs
that play a prominent role in TNF-α transcription in primary macrophages (192). The effects of
TNF-α in sh3bp2KI/KI are consistent with that of inflammatory bone loss in humans and mice. In
this study, sh3bp2KI/KI mice with pulp exposure showed more weight loss than those without pulp
exposure (Figure 7). Although naïve sh3bp2KI/KI mice start to loose weight after ages of 10 weeks,
the initial weight loss (14 days after pulp exposure) is a result of dental infection. Whether TNF-α
is further increased by dental infection which subsequently leads to more bone and body weight
loss still need further investigations.
In this study, radiographs of mandibles showed noticeable periapical radiolucency in the
sh3bp2KI/KI mice after 3 days of pulp exposure. Similar results were reported in studies using
different animal models (139, 143, 144). The onset of CBM in human is between 2-5 year-old.
CBM results in premature tooth exfoliation, jawbone loss, soft tissue inflammation and swelling.
In this study, at 14 days of pulp exposure, we observed the most extensive inflammatory responses
with root resorption and increased CatK-(+) cells in sh3bp2KI/KI mice and not in the control
sh3bp2KI/KI mice (Figure 13). This result suggests that AP accelerates the progression of CBM.
Progression of the periapical lesion is related to two events: 1) production of the pro-inflammatory
cytokines, such as IL-1, IL-6, and TNF-α; 2) cellular migration and osteoclast differentiation. Our
study points out that osteoclasts were associated with the resorption areas in the periapical regions
as well as surfaces of resorbed roots of the CBM mice. We observed the mean number of
osteoclasts from sh3bp2+/+ mice had a progressive and significant increase over 21 days after pulp
exposure. This result was similar to a previous publication that showed progressive increase of
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osteoclast numbers at 7, 21, and 42 days after pulp exposure (161). The authors also suggested that
cementocytes expressing RANKL, but not osteocytes, may also be involved in the modulation of
AP. In addition, bacterial products such as LPS stimulate IL-1β and TNF-α production, thereby
inducing osteoclast activity (193). Kawashima and Stashenko determined the kinetics of
expression of bone resorption and regulatory cytokines in a mouse model of AP (145). They
showed that there is a clear relationship between the expression of IL-1α mRNA and protein and
periapical bone resorption. A significant large amount of IL-1α production was observed at 7 days
after pulp exposure. TNF-α mRNA and protein also significantly increased in response to pulpal
infection. The correlation between TNF-α and IL-1α may be related to their co-stimulatory effects.
According to the authors, TNF-α may promote bone destruction indirectly through the induction
of IL-1α, and adjacent bone cells constitutively produce TNF-α which is involved in normal bone
homeostasis diffusing into the lesion (145). Moreover, they observed that IL-6, IL-2, IL-12, IFNγ, IL-4 and IL-10 protein levels increased after pulp exposure, but no IL-6 mRNA was detected.
This result was explained by the fact that IL-6 may have an extremely short half-life and may be
difficult to amplify by PCR, or IL-6 protein may not have been produced within the periapical
lesion but likely due to blood circulation. IL-12 may be produced by T-lymphocyte and IL-12 by
macrophages and Th1 cells inducing production of IFN-γ. IFN-γ seems to have contradictory
effects on bone resorption activity. It activates macrophages to produce cytokines such as IL-1 and
TNF-α, but also inhibits osteoclast formation, development and function (145). IL-4 and IL-10 are
Th2-type cytokines that inhibit cytokine production from activated T cells and macrophages.
Therefore, inflammatory bone resorption may be upregulated in vivo by Th1-type mediators, and
downregulated by Th2-type mediators (145). We speculate that bacterial products in the periapical
region of sh3bp2KI/KI mice might increase the inflammatory response, leading to the production of
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higher levels of TNF-α activating the osteoclasts. Future studies need to be performed to confirm
the role of cytokines after induction of AP in CBM mice.
Our results also show that there is a positive correlation between CatK(+)-cell number and
inflammation in sh3bp2KI/KI mice. CatK is a lysosomal cysteine protease that is highly expressed
in osteoclasts and has been implicated in the pathogenesis of osteoporosis and other bone diseases
(194). Due to its high matrix-degrading activity, CatK(+) cells are characterized by an enhanced
specific proteolytic capability (195). CatK has been shown to have functions in both osteoclasts
and immune cells, such as macrophages and dendritic cells (196, 197). Patients with endodontic
disease suffer from both inflammation-induced tissue damage and bone loss (96). Inhibition of
Catk using the specific small-molecule odanacatib (ODN) by oral administration in a periapical
lesion mouse model reduced bone resorption by inhibition of the osteoclast function (activation
and differentiation) and inflammation simultaneously (7). Gao et al., found that osteoclast
function was impaired and bone resorption was reduced significantly by applying gene therapeutic
approach to knockdown of CatK gene expression in periapical tissue in a mouse model. CatK
knockdown gene therapy may significantly reduce the severity of endodontic disease providing a
novel approach for the pathogenesis and intervention of endodontic and periapical diseases (198).
So far, there is no reports on how AP develops in CBM mice. However, animal studies
have shown that AP is induced by inflammation and destruction of periapical tissues. For instance,
it was demonstrated that MMP-9 KO and TLR2 KO animals developed larger periapical lesions
with greater inflammatory response, indicating important roles of MMP-9 and TLR2 in the host's
immune and inflammatory response to root canal and peri-radicular infection (185, 199). A recent
study on TLR2 KO mice showed a reduction of MMP2 expression and an increase of MMP9
expression in the final stage of AP (200). Wu et al., showed that 5-LO deficiency impaired the host
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innate immune system and aggravated AP in an experimental murine AP model (201). 5-LO
mediates RANKL-induced osteoclast formation and plays protective roles in the immune response.
Zhang et al. reported that AP elevated the levels of cytokines in rat blood serum, causing reversible
changes in the aortic arch, myocardium, and spleen as well as irreversible changes in the liver
(151).
Analyses of feeding behavior and weight gain appear to be correlated with the degree of
tooth injury. Pulp exposure injuries resulted in delayed resumption of normal weight in rats (202).
Diabetic animals were more susceptible to significant weight loss, morbidity and mortality after
induction of periapical lesions (203). Chundler and Byers showed that tooth injuries result in
behavioral changes similar to other pain models such as yawning, reduced body weight gain and
decreased time spent. They also showed that weight recovered by day three in rats with two teeth
injuries but remained low in those rats with three to four teeth injuries (204). Our study shows that
while sh3bp2+/+ and sh3bp2+/KI mice recovered after initial weight loss at 7 days, sh3bp2KI/KI mice
continued to lose weight after pulp exposure for 21 days. This data suggest that sh3bp2KI/KI mice
may suffer from more pain associated with tooth injury in comparison to their sh3bp2+/+ and
sh3bp2+/KI littermates. It is still unknown whether sh3bp2KI/KI mice develop SAP. However, it is
possible that these mice have increased inflammatory pain due to their continuous weight loss, as
weight loss is considered an index of pain in mice with tooth injuries (202, 204). There is
considerable evidence in humans that weight loss occurs in association with dental injury (205,
206). Importantly, it has been shown that after dental interventions to treat caries and alleviate pain
and infection, children quickly recover their weight and achieve normal growth (207, 208). One
hypothesis is that patient with dental pain has difficulty to eat (209).
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More studies are needed such as examining the gene or proteomic profiles of apical
periodontitis to evaluate whether any pain–related marker genes are differentially regulated in
sh3bp2KI/KI mice. The correlation of these cytokines in addition to the pain-related pain marker
might lead to the development of SAP in a mouse model.
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Chapter VI: Conclusion and future directions
We concluded that sh3bp2KI/KI mice developed larger periapical lesions with a greater
number of CatK(+) osteoclasts compared with the sh3bp2+/+ animals, indicating the important
effect of SH3BP2 during the immune and inflammatory response against the infection of root canal
system and periapical tissues. Also, AP exacerbate host inflammatory response in CBM mice.
Based on this study, we suggest that dentists should close monitor CBM patients to prevent AP.
Future studies will elucidate role of inflammatory cells such as neutrophils, expression of
cytokines, pain–related marker genes and proteomic profiles to determine the mechanism that
regulates AP in sh3bp2KI/KI mice.
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